Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-24 Purchase | 2022-10-26 8:01 pm | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 800,000 | $17 | $13,600,000 | 16,080 (Indirect) | View |
| 2022-09-13 Purchase | 2022-09-15 6:53 pm | Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner | 5,000,000 | $1.5 | $7,500,000 | 13,854,098 (Indirect Direct) | View |
| 2021-07-30 Purchase | 2021-08-03 9:06 pm | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 1,600,000 | $10 | $16,000,000 | 4,500,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-05 Option Award | 2023-01-06 4:19 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 536 | $0 | 44,056,353 (Direct) | View |
| 2022-10-24 Conversion | 2022-10-26 8:01 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 41,410,655 | $0 | 16,080 (Indirect) | View |
Ownership(A) | 2022-10-24 4:40 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 0 | $0 | 16,080 (Indirect) | View |
Ownership | 2022-10-19 8:03 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 0 | $0 | 11,456,594 (Indirect) | View |
| 2022-10-05 Option Award | 2022-10-06 4:06 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 321 | $0 | 44,055,817 (Direct) | View |
| 2022-09-02 Other | 2022-09-07 8:30 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,333 | $0 | 1,662,347 (Indirect) | View |
| 2022-08-30 Other | 2022-09-01 5:22 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,346 | $0 | 1,604,027 (Indirect) | View |
| 2022-08-24 Other | 2022-08-26 5:15 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,346 | $0 | 1,545,681 (Indirect) | View |
| 2022-08-18 Other | 2022-08-22 5:15 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 529,173 | $0 | 958,162 (Indirect) | View |
| 2022-08-12 Other | 2022-08-16 9:05 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,587,519 | $0 | 1,987,335 (Indirect) | View |
| 2022-07-05 Option Award | 2022-07-07 4:30 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director | 266 | $0 | 44,055,496 (Direct) | View |
| 2022-06-08 Other | 2022-06-10 9:24 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 529,173 | $0 | 841,470 (Indirect) | View |
| 2022-06-08 Option Award | 2022-06-10 4:18 pm | N/A 2032-06-07 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 36,477,716 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 6:31 pm | N/A 2032-06-05 | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-06-02 Other | 2022-06-06 8:25 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 529,173 | $0 | 11,207,361 (Indirect) | View |
| 2022-05-23 Option Award | 2022-05-25 6:38 pm | 2023-05-23 2032-05-22 | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 19,215 | $0 | 19,183,424 (Direct) | View |
| 2021-12-20 Other(A) | 2022-05-10 5:26 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 102,041 | $0 | 349,587 (Direct) | View |
| 2022-04-05 Option Award | 2022-04-06 5:54 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director | 230 | $0 | 44,055,230 (Direct) | View |
| 2021-12-20 Other | 2021-12-22 6:00 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,852,041 | $0 | 12,773,496 (Indirect) | View |
| 2021-11-29 Other | 2021-12-01 6:31 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 529,153 | $0 | 12,336,334 (Indirect) | View |
| 2021-11-22 Other | 2021-11-24 5:59 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 529,153 | $0 | 12,589,400 (Indirect) | View |
| 2021-08-05 Other | 2021-08-09 8:31 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN Member of 10% owner group 10% Owner | 701,250 | $0 | 4,465,000 (Indirect) | View |
| 2021-07-30 Other | 2021-08-03 9:06 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 650,000 | $10 | 4,500,000 (Indirect) | View |
Ownership | 2021-07-27 9:58 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 5,166,250 (Indirect) | View |
| 2021-07-20 Conversion | 2021-07-20 8:53 pm | N/A N/A | Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 18,794,443 | $0 | 5,527,777 (Indirect) | View |
Ownership | 2021-07-15 9:06 pm | N/A N/A | Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 11,055,554 (Indirect) | View |
| 2021-07-01 Other | 2021-07-06 4:48 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 4,047,897 | $0 | 16,361,210 (Indirect) | View |
| 2021-06-30 Other | 2021-07-02 5:19 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner | 208,052 | $0 | 3,357,682 (Indirect) | View |
| 2021-06-25 Other | 2021-06-29 5:22 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner | 416,104 | $0 | 3,961,048 (Indirect) | View |
| 2021-06-22 Other | 2021-06-24 5:05 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,011,974 | $0 | 15,535,142 (Indirect) | View |
| 2021-06-21 Conversion | 2021-06-23 5:38 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 54,619,074 | $0 | 18,206,358 (Indirect) | View |
| 2021-06-21 Conversion | 2021-06-23 4:29 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 25,739,146 | $0 | 1,254,405 (Indirect) | View |
Ownership | 2021-06-16 7:35 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 2,508,809 (Indirect) | View |
Ownership | 2021-06-16 7:20 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 0 | $0 | 36,412,716 (Indirect) | View |
| 2021-06-02 Option Award | 2021-06-04 6:35 pm | N/A 2031-06-02 | Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director | 8,296 | $0 | 9,687,403 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 8:55 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director | 3,253 | $0 | 10,684,182 (Direct) | View |
| 2021-03-22 Other | 2021-06-03 8:55 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director | 1,005,075 | $0 | 10,684,182 (Indirect) | View |
| 2021-05-21 Option Award | 2021-05-25 4:44 pm | 2022-05-21 2031-05-20 | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 10,122 | $0 | 26,700,739 (Direct) | View |
| 2021-04-21 Other | 2021-04-27 8:28 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 12,500 | $0 | 44,067,500 (Indirect) | View |
| 2021-04-13 Other | 2021-04-15 5:20 pm | N/A N/A | Karuna Therapeutics Inc. | KRTX | NELSEN ROBERT Director 10% Owner | 76,756 | $0 | 1,613,460 (Indirect) | View |